Concepedia
Statistics
Publications
20
Citations
1.6K
H-Index
17
Active since
1990
Affiliations
GlaxoSmithKline (United States)(Current)
Pfizer (United States)
Bristol-Myers Squibb (United States)
AstraZeneca (United Kingdom)
Sanofi (France)
Daniela Ennulat is an author at GlaxoSmithKline (United States) specializing in toxicology, medicine, and renal disease.
Publications per year
1990–2020
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
Frank Dieterle, Frank D. Sistare, Federico Goodsaid et al. · Nature Biotechnology · 2010 · 406 citations
Medicine, Nephrology, Precision Medicine +13
Distinct sequence elements control the specificity of G protein activation by muscarinic acetylcholine receptor subtypes.
James D. Lechleiter, Renate Hellmiss, Kevin Duerson et al. · The EMBO Journal · 1990 · 193 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +16
STP Position Paper: Best Practice Guideline for the Routine Pathology Evaluation of the Immune System
Patrick J. Haley, Richard Perry, Daniela Ennulat et al. · Toxicologic Pathology · 2005 · 159 citations
Life Sciences, Pathology, Toxicology +10
Biological Qualification of Biomarkers of Chemical-Induced Renal Toxicity in Two Strains of Male Rat
Ernie Harpur, Daniela Ennulat, David Hoffman et al. · Toxicological Sciences · 2011 · 121 citations · Full text
Medicine, Pathology, Toxicology +17
Effects of Hepatic Drug-metabolizing Enzyme Induction on Clinical Pathology Parameters in Animals and Man
Daniela Ennulat, Dana B. Walker, F. A. S. Clemo et al. · Toxicologic Pathology · 2010 · 88 citations · Full text
Medicine, Pharmacology, Toxicology +17
1–5 of 20